McDermott + Bull Partner Ken Dropiewski interviews BioStar Capital’s Founder + Senior Managing Director Louis Cannon and Managing Director Alan Davis in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken, Louis, and Alan discuss what differentiates them from other venture capital groups, details about their new fund, focus areas, and much more!
Investor Insights: Ken Dropiewski with Louis Cannon, MD and Alan Davis, MD of BioStar Capital
